Ian Gilron will provide a recently updated evidence-based review of combination pharmacotherapy for neuropathic pain in order to highlight critical issues surrounding optimal combinations and necessary improvements for future combination trials. Key issues relating to combination therapy will be discussed including: 1) safety 2) simultaneous versus sequential “add-on” therapy; and 3) optimal use of fixed dose combinations.